28 results on '"Schuitemaker, Hanneke"'
Search Results
2. Cross-Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression
3. A Nonprogressive Clinical Course in HIV-Infected Individuals Expressing Human Leukocyte Antigen B57/5801 Is Associated with Preserved CD8⁺ T Lymphocyte Responsiveness to the HW9 Epitope in Nef
4. GB Virus C Coinfection and HIV-1 Disease Progression: The Amsterdam Cohort Study
5. Decreasing Sensitivity to RANTES (Regulated on Activation, Normally T Cell-Expressed and -Secreted) Neutralization of CC Chemokine Receptor 5-Using, Non-Syncytium-Indudng Virus Variants in the Course of Human Immunodeficiency Virus Type 1 Infection
6. Increased in vitro Cytopathicity of CC Chemokine Receptor 5-Restricted Human Immunodeficiency Virus Type 1 Primary Isolates Correlates with a Progressive Clinical Course of Infection
7. Adaptation to Promiscuous Usage of Chemokine Receptors Is Not a Prerequisite for Human Immunodeficiency Virus Type 1 Disease Progression
8. Reduced Prevalence of the CCR5 ∆32 Heterozygous Genotype in Human Immunodeficiency Virus-Infected Individuals with AIDS Dementia Complex
9. No Evidence for an Effect of the CCR5 Δ32/+ and CCR2b 64I/+ Mutations on Human Immunodeficiency Virus (HIV)-1 Disease Progression among HIV-1-Infected Injecting Drug Users
10. Relation of Phenotype Evolution of HIV-1 to Envelope V2 Configuration
11. Transmission of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Variants following Deliberate Injection of Blood from a Patient with AIDS: Characteristics and Natural History of the Virus
12. Role of CCR2 Genotype in the Clinical Course of Syncytium-Inducing (SI) or Non-SI Human Immunodeficiency Virus Type 1 Infection and in the Time to Conversion to SI Virus Variants
13. Longitudinal Analysis of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocyte Responses: A Predominant Gag-Specific Response Is Associated with Nonprogressive Infection
14. Emergence of Syncytium-Inducing Human Immunodeficiency Virus Type 1 Variants Coincides with a Transient Increase in Viral RNA Level and Is an Independent Predictor for Progression to AIDS
15. In vitro Replication Kinetics of Human Immunodeficiency Virus Type 1 (HIV-1) Variants in Relation to Virus Load in Long-Term Survivors of HIV-1 Infection
16. Temporal Relationship between Human Immunodeficiency Virus Type 1 RNA Levels in Serum and Cellular Infectious Load in Peripheral Blood
17. Changes in Cellular Virus Load and Zidovudine Resistance of Syncytium-Inducing and Non-Syncytium-Inducing Human Immunodeficiency Virus Populations under Zidovudine Pressure: A Clonal Analysis
18. Relation between Changes in Cellular Load, Evolution of Viral Phenotype, and the Clonal Composition of Virus Populations in the Course of Human Immunodeficiency Virus Type 1 Infection
19. Lack of T Cell Dysfunction and Programmed Cell Death in Human Immunodeficiency Virus Type 1-Infected Chimpanzees Correlates with Absence of Monocytotropic Variants
20. Capacity of Human Immunodeficiency Virus Type 1 to Infect Chimpanzee Monocytes in vitro
21. Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge.
22. Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.
23. Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination.
24. Envelope V2 Configuration and HIV-1 Phenotype: Clarification
25. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates.
26. MOESM3 of HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
27. MOESM3 of HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
28. Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.